Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Weight Loss With Atogepant in Participants with Migraine and Overweight or Obesity: Interim Analysis of a Phase 3, Multicenter, Open-label, 156-week Extension Study